Prospera Financial Services’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Prospera Financial Services’s Portfolio CNCR Stock Details CNCR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$166K	Hold
2023 Q4	$135K	Hold
2023 Q3	$110K	Hold
2023 Q2	$129K	Hold
2023 Q1	$120K	Hold
2022 Q4	$137K	Buy
2022 Q2	–	Sell
2022 Q1	$180K	Hold
2021 Q4	$238K	Buy